State officials reports 185 more coronavirus cases and one death Monday, and its director says new infections are outpacing the agency’s ability to keep up.
vaccine
AstraZeneca: COVID-19 vaccine ‘highly effective’ prevention
Unlike the Pfizer and Moderna vaccines, the Oxford-AstraZeneca candidate doesn’t have to be stored at ultra-cold temperatures, making it easier to distribute.
Pfizer seeks OK for emergency use of COVID-19 vaccine in U.S.
The public’s first chance to see how strong the evidence of its effectiveness really is will come in early December at a public meeting of the FDA’s scientific advisers.
Trump touts progress on vaccine in first remarks since election loss
The president rules out a nationwide ‘lockdown’ but appears to acknowledge the decision won’t be his much longer.
Maine CDC tackles vaccine challenges as Pfizer announces promising results
Cold storage requirements are a logistics issue for the Pfizer vaccine, says Dr. Nirav Shah, Maine’s CDC director.
Three Sanford students given flu shots without parents’ approval
During a flu shot clinic put on by Northern Light Health Care, 3 students in the school district were administered a flu vaccine without proper consent.
UK to infect healthy volunteers in vaccine research trial
This type of research, known as a human challenge study, is used infrequently because some consider the risk involved in infecting otherwise healthy individuals to be unethical.
Maine’s plan to distribute vaccine stresses racial equity, health care workers and the elderly
The plan submitted to the federal government Friday calls for vaccinating 80% of Maine’s 1.3 million people within 12 weeks, in a massive statewide effort.
Young, healthy people may have to wait until 2022 for vaccine, top WHO scientist says
Any vaccine that is ready next year will be available in limited quantities, with health-care workers and others on the front lines having first priority.
Worries about a virus vaccine grow and experts are planning extra scrutiny
U.S. health officials are planning an extra layer of safety scrutiny for the first people vaccinated when shots become available.